[Clinical studies on the pharmacoeconomic expediency of the use of fluoroquinolones].
Mokhov
O I
OI
Bayer AO Research Group, Moscow.
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000191:economics / Q000627:therapeutic use*; D004311:Double-Blind Method; D017850:Economics, Pharmaceutical; D024841:Fluoroquinolones; D006801:Humans; D007275:Injections, Intravenous; D016032:Randomized Controlled Trials as Topic; D012426:Russia; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D024841:Fluoroquinolones